A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor. | EBSCOhost

Connecting you to content on EBSCOhost

Title: A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor.
Authors: Limon, Dror; Amiel, Alexandra; Haim, Shaked Even; Gordon, Noa; Tschernichovsky, Roi; Stemmer, Salomon; Gal, Omer; Laviv, Yosef; Kanner, Andrew; Siegal, Tali; Yust-Katz, Shlomit
Publication: Neuro-Oncology Advances, 2024, Vol 6, Issue 1, p1
Publication type: Academic Journal
DOI: 10.1093/noajnl/vdae154